Research to End Healthcare Disparities
Contains the following within
Co-occurring mental health and substance use disorders (SUD) are common among individuals that receive psychiatric services, yet it is rare for provider in the mental health system to provide concurrent services for SUDs.
Successfully completing a substance use disorder treatment episode is an important milestone for clients, but most of these episodes still result in relapse. Ultimately, successful completion requires abstinence, a determined period of non-use of any legal or illegal drugs, before discharge from treatment.
Emergency room overuse has increased markedly within the United States, particularly in non-urgent cases related to substance use disorders, which comprised over 45 percent of the total number of emergency room visits in 2009.
Dr. Ben Cook, from Havarvard Medical School explains an innovative model to measure treatment disparities.
Greater accessibility to outpatient substance use disorder treatment can greatly assist those struggling with substance abuse issues despite existing treatment barriers such as insurance coverage, racial/ethnic discrimination and culturally responsive care.
Effective leadership, organizational readiness for change, and acceptance of Medi-Cal have each been shown to be associated with reducing disparities in substance use disorder treatment outcomes. These three important organizational characteristics can represent “program capacity.”
Delivery of evidence-based and culturally responsive substance use disorder treatment (SUD) has been shown to improve treatment adherence among Latinos, yet these practices are not routinely delivered in SUD treatment settings.
Dr. Hector Rodriguez, from UC Berkeley discusses latest findings in coordination and patient engagement in accountable care organizations.
Since 1999, deaths from opioid overdoses have skyrocketed, becoming the worst drug epidemic in modern American history
Numerous factors, including violence, political turbulence and drug trafficking within Mexico and the United States, have contributed to transnationals’ increased access to drugs and illegal drug activity.
